Fibrinolytic therapy, also known as thrombolytic therapy, is used to dissolve dangerous blood clots formed inside arteries or veins that can reduce or block blood flow. Fibrinolytic drugs, also called thrombolytic drugs, dissolve clots by activating plasminogen to break down fibrin, a protein that forms blood clots. Streptokinase, urokinase, and tissue plasminogen activators are some common...
Global fibrinolytic therapy market is estimated to be valued at US$ 34.96 Bn in 2024 and is expected to exhibit a CAGR of 3.7% over the forecast period 2023 to 2030. Fibrinolytic therapy, also known as thrombolysis, involves the administration of clot-busting drugs to dissolve blood clots that form inside arteries and veins due to cardiovascular diseases such as myocardial infarction, pulmonary...